AYTU BIOPHARMA, INC. FDA Approval Prediction
Resolves: The company receives FDA approval for its lead drug candidate.
sec_filing· REGULATORY
AYTU BIOPHARMA, INC. FDA Approval Prediction
Market overview
Derived from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) 10-Q filing analysis
REGULATORY prediction market
- Implied probability (Yes)
- 50%
- Closes
- 2027-03-31
About this prediction
Resolution criteria
The company receives FDA approval for its lead drug candidate.
More REGULATORY markets
- Spain’s joint debt plan gains partial EU backing by Q1 2027 — 55% Yes
- By 2026-12-31, at least two of Amazon, Google, or Microsoft will adopt U.N.-aligned AI environmental transparency standards — 75% Yes
- U.S. Treasury to finalize new bank liquidity rules by December 2026 — 75% Yes
- IMF approves $5B debt relief package for 18 high-debt countries by March 2027 — 72% Yes
- Private ADHD care providers face UK crackdown by 2027 — 80% Yes
- Burnham's water and energy nationalization pledge enacted within 6 months — 70% Yes
- EU regulator fines Apple over new fee structure — 55% Yes
- EU adopts Macron’s sports protectionism plan by 2027 — 70% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…